BrightAccountsProduction v1.0.0 v1.0.0 2024-05-01 The company was not dormant during the period The company was trading for the entire period Unaudited Accounts 86230 - Dental practice activities 22 September 2025 0 0 05564801 2025-04-30 05564801 2024-04-30 05564801 2023-04-30 05564801 2024-05-01 2025-04-30 05564801 2023-05-01 2024-04-30 05564801 uk-bus:PrivateLimitedCompanyLtd 2024-05-01 2025-04-30 05564801 uk-curr:PoundSterling 2024-05-01 2025-04-30 05564801 uk-bus:AbridgedAccounts 2024-05-01 2025-04-30 05564801 uk-bus:Director1 2024-05-01 2025-04-30 05564801 uk-bus:RegisteredOffice 2024-05-01 2025-04-30 05564801 uk-bus:Agent1 2024-05-01 2025-04-30 05564801 uk-core:ShareCapital 2025-04-30 05564801 uk-core:ShareCapital 2024-04-30 05564801 uk-core:RetainedEarningsAccumulatedLosses 2025-04-30 05564801 uk-core:RetainedEarningsAccumulatedLosses 2024-04-30 05564801 uk-core:TotalEquityAttributableToOwnersParentBeforeNon-controllingInterests 2025-04-30 05564801 uk-core:TotalEquityAttributableToOwnersParentBeforeNon-controllingInterests 2024-04-30 05564801 uk-bus:FRS102 2024-05-01 2025-04-30 05564801 uk-core:Goodwill 2024-05-01 2025-04-30 05564801 uk-core:PlantMachinery 2024-05-01 2025-04-30 05564801 uk-core:FurnitureFittingsToolsEquipment 2024-05-01 2025-04-30 05564801 uk-core:MotorVehicles 2024-05-01 2025-04-30 05564801 uk-core:Goodwill 2024-04-30 05564801 uk-core:Goodwill 2025-04-30 05564801 2024-05-01 2025-04-30 05564801 uk-bus:AuditExempt-NoAccountantsReport 2024-05-01 2025-04-30 xbrli:pure iso4217:GBP xbrli:shares
 
 
 
Dormon Laboratories Limited
 
Abridged Unaudited Financial Statements
 
for the financial year ended 30 April 2025



Dormon Laboratories Limited
DIRECTOR AND OTHER INFORMATION

 
Director Christopher John Dormon
 
 
Company Registration Number 05564801
 
 
Registered Office Grenville House,
4 Grenville Avenue,
BROXBOURNE
Hertfordshire
EN10 7DH
United Kingdom
 
 
Accountants Lincoln Brown & Co Limited
Chartered Certified Accountants
Grenville House
4 Grenville Avenue
Herts
EN10 7DH
United Kingdom



Dormon Laboratories Limited
Company Registration Number: 05564801
ABRIDGED STATEMENT OF FINANCIAL POSITION
as at 30 April 2025

2025 2024
Notes £ £
 
Non-Current Assets
Property, plant and equipment 5 16,552 25,483
───────── ─────────
 
Current Assets
Debtors 15,638 14,245
Cash and cash equivalents 3,906 2,861
───────── ─────────
19,544 17,106
───────── ─────────
Creditors: amounts falling due within one year (9,192) (9,636)
───────── ─────────
Net Current Assets 10,352 7,470
───────── ─────────
Total Assets less Current Liabilities 26,904 32,953
═════════ ═════════
 
Capital and Reserves
Called up share capital 1 1
Retained earnings 26,903 32,952
───────── ─────────
Shareholders' Funds 26,904 32,953
═════════ ═════════
 
The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A (Small Entities).
           
All of the members have consented to the preparation of abridged accounts in accordance with section 444(2A) of the Companies Act 2006.
           
The company has taken advantage of the exemption under section 444 not to file the Abridged Income Statement and Director's Report.
For the financial year ended 30 April 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006.
           
The director confirms that the members have not required the company to obtain an audit of its financial statements for the financial year in question in accordance with section 476 of the Companies Act 2006.
           
The director acknowledges their responsibilities for ensuring that the company keeps accounting records which comply with section 386 and for preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of the financial year and of its profit and loss for the financial year in accordance with the requirements of sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.
           
Approved by the Director and authorised for issue on 22 September 2025
           
           
________________________________          
Christopher John Dormon          
Director          
           



Dormon Laboratories Limited
NOTES TO THE ABRIDGED FINANCIAL STATEMENTS
for the financial year ended 30 April 2025

   
1. General Information
 
Dormon Laboratories Limited is a company limited by shares incorporated and registered in the United Kingdom. The registered number of the company is 05564801. The registered office of the company is Grenville House,, 4 Grenville Avenue,, BROXBOURNE, Hertfordshire, EN10 7DH, United Kingdom. 86230 - Dental practice activities The financial statements have been presented in Pound (£) which is also the functional currency of the company.
         
2. Summary of Significant Accounting Policies
 
The following accounting policies have been applied consistently in dealing with items which are considered material in relation to the company's financial statements.
 
Statement of compliance
The financial statements of the company for the financial year ended 30 April 2025 have been prepared in accordance with the provisions of FRS 102 Section 1A (Small Entities) and the Companies Act 2006.
 
Basis of preparation
The financial statements have been prepared on the going concern basis and in accordance with the historical cost convention except for certain properties and financial instruments that are measured at revalued amounts or fair values, as explained in the accounting policies below. Historical cost is generally based on the fair value of the consideration given in exchange for assets.
 
Turnover
Turnover comprises the invoice value of goods supplied by the company, exclusive of trade discounts and value added tax.
 
Goodwill
Purchased goodwill arising on the acquisition of a business represents the excess of the acquisition cost over the fair value of the identifiable net assets including other intangible fixed assets when they were acquired. Purchased goodwill is capitalised in the Statement of Financial Position and amortised on a straight line basis over its economic useful life of 0 years, which is estimated to be the period during which benefits are expected to arise.  On disposal of a business any goodwill not yet amortised is included in determining the profit or loss on sale of the business.
 
Property, plant and equipment and depreciation
Property, plant and equipment are stated at cost or at valuation, less accumulated depreciation. The charge to depreciation is calculated to write off the original cost or valuation of property, plant and equipment, less their estimated residual value, over their expected useful lives as follows:
 
  Plant and machinery - 20% Reducing balance
  Fixtures, fittings and equipment - 20% Reducing balance
  Motor vehicles - 20% Reducing balance
 
The carrying values of tangible fixed assets are reviewed annually for impairment in periods if events or changes in circumstances indicate the carrying value may not be recoverable.
 
Trade and other debtors
Trade and other debtors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method less impairment losses for bad and doubtful debts except where the effect of discounting would be immaterial. In such cases the receivables are stated at cost less impairment losses for bad and doubtful debts.
 
Trade and other creditors
Trade and other creditors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest rate method, unless the effect of discounting would be immaterial, in which case they are stated at cost.
 
Employee benefits
The company operates a defined contribution pension scheme. The assets of the scheme are held separately from those of the company in an independently administered fund. The company also operates a defined benefit pension scheme for its employees providing benefits based on final pensionable pay. The assets of this scheme are also held separately from those of the company, being invested with pension fund managers.
 
Taxation and deferred taxation
Current tax represents the amount expected to be paid or recovered in respect of taxable profits for the financial year and is calculated using the tax rates and laws that have been enacted or substantially enacted at the Statement of Financial Position date.

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date where transactions or events have occurred at that date that will result in an obligation to pay more tax in the future, or a right to pay less tax in the future. Timing differences are temporary differences between the company's taxable profits and its results as stated in the financial statements. Deferred tax is measured on an undiscounted basis at the tax rates that are anticipated to apply in the periods in which the timing differences are expected to reverse, based on tax rates and laws that have been enacted or substantively enacted by the Statement of Financial Position date.
 
Ordinary share capital
The ordinary share capital of the company is presented as equity.
       
3. Employees
 
The average monthly number of employees, including director, during the financial year was 2, (2024 - 2).
       
4. Intangible assets
     
  Goodwill Total
  £ £
Cost
At 1 May 2024 8,500 8,500
  ───────── ─────────
 
At 30 April 2025 8,500 8,500
  ───────── ─────────
Amortisation
 
At 30 April 2025 8,500 8,500
  ───────── ─────────
Net book value
At 30 April 2025 - -
  ═════════ ═════════
           
5. Property, plant and equipment
  Plant and Fixtures, Motor Total
  machinery fittings and vehicles  
    equipment    
  £ £ £ £
Cost
At 1 May 2024 32,892 4,280 46,880 84,052
Disposals - - (14,990) (14,990)
  ───────── ───────── ───────── ─────────
At 30 April 2025 32,892 4,280 31,890 69,062
  ───────── ───────── ───────── ─────────
Depreciation
At 1 May 2024 27,014 2,979 28,576 58,569
Charge for the financial year 1,176 260 3,661 5,097
On disposals - - (11,156) (11,156)
  ───────── ───────── ───────── ─────────
At 30 April 2025 28,190 3,239 21,081 52,510
  ───────── ───────── ───────── ─────────
Net book value
At 30 April 2025 4,702 1,041 10,809 16,552
  ═════════ ═════════ ═════════ ═════════
At 30 April 2024 5,878 1,301 18,304 25,483
  ═════════ ═════════ ═════════ ═════════
       
6. Capital commitments
 
The company had no material capital commitments at the financial year-ended 30 April 2025.
   
7. Events After the End of the Reporting Period
 
There have been no significant events affecting the company since the financial year-end.